Evidence map›Paper›PMID 33985815›Full record

ReviewTrends in pharmacological sciences2021

Structural insights into ligand recognition and activation of angiotensin receptors.

Haitao Zhang, Aleksandra Luginina, Alexey Mishin, Mithu Baidya, Arun K Shukla, Vadim Cherezov

Open access · greenAbstract readReview
In one paragraph

Review in Trends in pharmacological sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 4 countries.

Haitao ZhangHangzhou Institute of Innovative Medicine, Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China. Electronic address: haitaozhang@zju.edu.cn.
Aleksandra LugininaResearch Center for Molecular Mechanisms of Aging and Age-Related Diseases, Moscow Institute of Physics and Technology, Dolgoprudny, Moscow Region, Russia.
Alexey MishinResearch Center for Molecular Mechanisms of Aging and Age-Related Diseases, Moscow Institute of Physics and Technology, Dolgoprudny, Moscow Region, Russia.
Mithu BaidyaDepartment of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur, India.
Arun K ShuklaDepartment of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur, India. Electronic address: arshukla@iitk.ac.in.
Vadim CherezovResearch Center for Molecular Mechanisms of Aging and Age-Related Diseases, Moscow Institute of Physics and Technology, Dolgoprudny, Moscow Region, Russia; Bridge Institute, Departments of Chemistry and Biological Sciences, University of Southern California, Los Angeles, CA, USA. Electronic address: cherezov@usc.edu.
Moscow Institute of Physics and Technology · RUIndian Institute of Technology Kanpur · INZhejiang University · CN

Funding

DBT-Wellcome Trust India Alliance IA/S/20/1/504916
6 · The paper itself

Abstract

G protein-coupled angiotensin II receptors, AT

Indexed as

Angiotensin Receptor AntagonistsReceptor, Angiotensin, Type 1Angiotensin-Converting Enzyme InhibitorsHumansLigandsRenin-Angiotensin SystemAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsLigandsReceptor, Angiotensin, Type 1activation mechanismangiotensin II receptorsbiased signalingG protein-coupled receptorsligandsubtype selectivity

Identifiers

PMID33985815
PMCPMC7611150
OpenAlexW3162785546

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.